Labiotech.eu

News and Trends 14 Mar 2023

Calliditas shares rise as phase 3 endpoints met in kidney disease trial

Swedish company Calliditas Therapeutics AB has announced positive topline results from the global, randomized, double-blind, placebo-controlled phase 3 clinical trial investigating the effect of Nefecon (TARPEYO/Kinpeygo (budesonide) delayed release capsules) versus placebo in patients with primary IgA nephropathy (IgAN). Calliditas share prices rose 30% in the aftermath of the announcement. IgAN, or Berger’s disease, is […]

March 14, 2023 - 4 minutesmins - By Jim Cornall

health innovation startups UK, PHTA Ltd, multi-disciplinary collaboration

Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges

The Covid-19 pandemic highlighted the importance of innovation in the healthcare space when tackling a public health challenge. Nonetheless, health innovation startups today face multiple hurdles, from sourcing funding, to obtaining access to the right expertise, and more. Of late, an additional hurdle that young life science businesses also have to contend with is the […]

March 14, 2023 - 6 minutesmins - By Sudha Sundaram

News and Trends 13 Mar 2023

New therapy for prevention and treatment of COVID-19

ExeVir Bio, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences institute, have published a pre-print paper by De Cae et al., entitled “Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane-proximal epitope of the spike.” Nearly all SARS-CoV-2 neutralizing antibodies used in the clinic show substantial loss of potency against the […]

March 13, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 13 Mar 2023

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per share in cash, representing an equity value of approximately $2.9 billion. The transaction adds […]

March 13, 2023 - 4 minutesmins - By Jim Cornall

In Depth 10 Mar 2023

Can CRISPR bring back extinct animals?

The concept of de-extinction has been around for many years. Once considered a fanciful idea, recent advancements in technology – notably CRISPR – have made bringing back extinct animals such as mammoths an extremely feasible proposition that investors are willing to put their money into, with an aim of reversing and preventing biodiversity loss. The […]

March 10, 2023 - 10 minutesmins - By Willow Shah-Neville

Meet some of the biotechs attending Bio-Europe Spring 2023

As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding biotech hub, the event will provide opportunities to engage with representatives of hundreds of companies from around the world. At the convention, exhibitors will be able to showcase their innovations and meet with prospective sponsors, […]

March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 9 Mar 2023

Twisted blood vessels reveal cancer treatment success potential

Picture Health has announced plans to commercialize a new artificial intelligence (AI)-powered biomarker with the potential to transform the way doctors decide how to treat cancer. The advancement in cancer outcomes research sheds new light on cancer tumors: analyzing the state of the blood vessels that feed them. Recently published studies have shown the technology […]

March 9, 2023 - 3 minutesmins - By Jim Cornall

artificial intelligence AI drug discovery

News and Trends 9 Mar 2023

Iktos raises €15.5M to expand AI drug discovery technologies

Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a €15.5 million ($16.4 million) Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. This financing will enable Iktos to further develop its AI and drug discovery capabilities and expand its existing SaaS software […]

March 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 9 Mar 2023

Researchers develop treatment for vancomycin-resistant bacteria

Researchers from several institutions have developed a treatment for bacteria resistant to vancomycin, which is also known as vancomycin-resistant Enterococcus faecalis (VRE). The group consists of researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with Singapore Centre for […]

March 9, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 9 Mar 2023

Ampersand Biomedicines launched to develop drugs that only work at disease sites

Flagship Pioneering has created Ampersand Biomedicines, a company creating programmable medicines that are intended to be safer, more tolerable, and effective by acting at the site of disease. Flagship Pioneering has initially committed $50 million to advance the company’s Address, Navigate, Design (AND) platform and develop an initial pipeline of medicines across a range of […]

March 9, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 9 Mar 2023

Beyond Biotech podcast 37: Natural killer cells, biopharma revenue, toxic shock syndrome vaccine

This week our guests are Marit Inngjerdingen from the Institute of Clinical Medicine in Norway; Kyle Forcier, senior director of life sciences product marketing at Model N; and Dr. Andreas Roetzer, head of R&D for vaccines at Biomedical Research & Bio-Products. The next breakthrough in cancer treatment? In our body, we have an innate immune […]

March 9, 2023

Best in Biotech 9 Mar 2023

5 advancements in kidney disease research over the past year

Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like blood and excess protein in urine, fluid retention causing swollen ankles, poor appetite and even the inability of the body to filter waste, resulting in acute kidney failure. To boost the research and development of treatments for kidney diseases, Kidney […]

March 9, 2023 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Calliditas shares rise as phase 3 endpoints met in kidney disease trial

Nurturing healthcare innovation: a multi-disciplinary ecosystem to overcome startup challenges

New therapy for prevention and treatment of COVID-19

Sanofi adds diabetes drug through Provention Bio $2.9B acquisition

Can CRISPR bring back extinct animals?

Meet some of the biotechs attending Bio-Europe Spring 2023

Twisted blood vessels reveal cancer treatment success potential

Iktos raises €15.5M to expand AI drug discovery technologies

Researchers develop treatment for vancomycin-resistant bacteria

Ampersand Biomedicines launched to develop drugs that only work at disease sites

Beyond Biotech podcast 37: Natural killer cells, biopharma revenue, toxic shock syndrome vaccine

5 advancements in kidney disease research over the past year

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!